Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Jentzmik, F; Stephan, C; Lein, M; Miller, K; Kamlage, B; Bethan, B; Kristiansen, G; Jung, K (2011). Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. The Journal of Urology, 185(2):706-711.

Schaefer, A; Jung, M; Kristiansen, G; Lein, M; Schrader, M; Miller, K; Stephan, C; Jung, K (2010). MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urologic Oncology, 28(1):4-13.

Esgueva, R; Perner, S; Lafargue, C J; Scheble, V; Stephan, C; Lein, M; Fritzsche, F R; Dietel, M; Kristiansen, G; Rubin, M A (2010). Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. Modern Pathology, (23):539-546.

Tölle, A; Jung, M; Lein, M; Johannsen, M; Miller, K; Moch, H; Jung, K; Kristiansen, G (2009). Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer, 9:248.

Schaefer, A; Jung, M; Kristiansen, G; Lein, M; Schrader, M; Miller, K; Erbersdobler, A; Stephan, C; Jung, K (2009). Mikro-RNA in der Uroonkologie. Neue Hoffnungen für die Diagnostik und Therapie von Tumoren? Der Urologe. Ausg. A, 48(8):877-885.

Fritzsche, F R; Jung, M; Tölle, A; Wild, P; Hartmann, A; Wassermann, K; Rabien, A; Lein, M; Dietel, M; Pilarsky, C; Calvano, D; Grützmann, R; Jung, K; Kristiansen, G (2008). ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. European Urology, 54(5):1097-1108.

Fritzsche, F R; Wassermann, K; Jung, M; Tölle, A; Kristiansen, I; Lein, M; Johannsen, M; Dietel, M; Jung, K; Kristiansen, G (2008). ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer, 8:179.

Kristiansen, G; Fritzsche, F R; Wassermann, K; Jäger, C; Tölle, A; Lein, M; Stephan, C; Jung, K; Pilarsky, C; Dietel, M; Moch, H (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. British Journal of Cancer, 99(6):939-948.

This list was generated on Tue Sep 19 13:08:04 2017 CEST.